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To investigate recognised co-morbidities and clinical management associated with inpatient
pneumonia mortality in Malawian district hospitals.
Methods
Prospective cohort study, of patient records, carried out in Malawi between 1st October
2000 and 30th June 2003. The study included all children aged 0-59 months admitted to the
paediatric wards in sixteen district hospitals throughout Malawi with severe and very severe
pneumonia. We compared individual factors between those that survived (n = 14 076) and
those that died (n = 1 633).
Results
From logistic regression analysis, predictors of death in hospital, adjusted for age, sex and
severity grade included comorbid conditions of meningitis (OR =2.49, 95% CI 1.50-4.15),
malnutrition (OR =2.37, 95% CI 1.94-2.88) and severe anaemia (OR =1.41, 95% CI 1.03-
1.92). Requiring supplementary oxygen (OR =2.16, 95% CI 1.85-2.51) and intravenous
fluids (OR =3.02, 95% CI 2.13-4.28) were associated with death while blood transfusion
was no longer significant (OR =1.10, 95% CI 0.77-1.57) when the model included severe
anaemia.
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Conclusions
This study identified a number of challenges to improve outcome for Malawian infants and
children hospitalised with pneumonia. These included improved assessment of co-morbidi-
ties and more rigorous application of standard case management.
Introduction
Pneumonia is consistently estimated to be the single major cause of death in infants and young
children (1–59 months of age) and almost all these deaths occur in low-income countries.
[1–3] It is estimated that approximately 50% of all deaths due to pneumonia in children occur
in sub-Saharan Africa. [4] However, there are a number of acknowledged limitations to attrib-
uting a death to a single disease entity. [5–7] First, in infants and young children with severe
pneumonia, co-morbidities such as malnutrition or HIV infection are common and increase
the risk of death. [8,9] Second, there is clinical overlap with diseases such as severe anaemia,
malaria or septicaemia that may result in death being wrongly attributed to pneumonia.
[10,11] Finally, it is also recognised that bacterial pneumonia can occur as a co-infection or
secondary complication in children with other infections such as measles, severe malaria or
tuberculosis. [12–14] Nonetheless, health workers in high mortality settings are required to
manage sick children according to standard case-management protocols on the basis of clinical
findings with very limited diagnostic support.
The World Health Organization (WHO) has clear clinical case-management guidelines that
aim to identify the child with pneumonia among the many infants and young children that
present to health services with an acute respiratory illness, and then to classify the pneumonia
case further by age and by severity. [15] These classifications determine whether the child with
pneumonia is managed as an inpatient or outpatient and the choice of antibiotic treatment.
[11] In general terms, the choice of penicillin is primarily aimed to treat pneumonia due to
Streptococcus pneumoniae, while a broad spectrum antibiotic is recommended as first-line anti-
biotic treatment for cases where pneumonia is associated with a high risk of mortality and/or is
often due to a wider range of bacterial pathogens, including Gram negative bacteria. The latter
group include very young infants (<2 months of age), malnourished children and children
with very severe pneumonia. [11,15] Therefore children 2 to 59 months of age classified as hav-
ing very severe pneumonia are to be given chloramphenicol for treatment; those classified as
having severe pneumonia are not. The WHO case-management guidelines also aim to avoid
the unnecessary use of antibiotics for upper respiratory tract illness only.
We recently reported outcomes from a prospective implementation programme that
included 47,228 Malawian children admitted to district hospitals in Malawi for severe and very
severe pneumonia over a five year period. [16, 17] We have further analysed data from a sub-
set of this cohort to determine the individual factors including demographics of the study pop-




We reviewed the sequential records of all infants and young children (< 5 years) that were
admitted to 16 district hospitals in Malawi between 1st October 2000 and 30th June 2003 as part
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of the Malawi Child Lung Health Programme (CLHP). The Malawi CLHP included a prospec-
tive evaluation of the implementation of standard case-management for 47,228 children admit-
ted with severe or very severe pneumonia to one of the 24 district hospitals in Malawi over a
5-year period (2000–2005).
The implementation, methodology, evaluation and main outcomes of the Malawi CLHP
have been described in detail in previous publications. [16, 17] Briefly, all neonates, infants and
young children between 1 week and 59 months of age hospitalised with a clinical diagnosis of
severe or very severe pneumonia, according to WHO definitions at the time, were included.
The implementation followed training of staff to follow the recommended WHO pneumonia
standard case management approach at the time of the study (Table 1) and it was ensured that
supplies of treatment for child pneumonia (i.e. recommended antibiotics and oxygen therapy)
were available. Oxygen was not available in all hospitals for the period of the study’s data col-
lection. The first five district hospitals who started implementing the CLHP in October 2000
received their concentrators in February 2002. The remaining 11 received their concentrators
in February 2003.
Study procedures
All children included in the Malawi CLHP were allocated a “Pneumonia Inpatient Recording
Form” which prospectively collected relevant data including demographic data, clinical data
including weight, classification of severity of pneumonia, detailed data of management, and
outcome data. In addition to training on the WHO standardised case-management approach
to child pneumonia, staff were also trained on the diagnosis and management (according to
national guidelines) of other related causes of common childhood illness such as malaria, anae-
mia or malnutrition.
The diagnosis and investigation of co-morbidities depended on clinical suspicion and usu-
ally clinical diagnosis. In addition, a thick blood film was examined for Plasmodium falciparum
malaria diagnosis, or a haematocrit or haemoglobin were determined for diagnosis of anaemia.
Chest radiography was not carried out routinely on admission but was used in those cases not
responding to first-line antibiotics. No diagnostic tools were available or used to determine
aetiological pathogen(s) causing pneumonia such as bacteria, viruses or fungi such as Pneumo-
cystis jirovecii. Testing for HIV infection was rarely undertaken at the time of this study.
Weight was plotted for age on the Road to Health Card, and severe malnutrition was diag-
nosed if there was severe wasting or nutritional oedema. Severe malaria was diagnosed clini-
cally in children with altered consciousness and/or convulsions
Data management
Data from the Inpatient Recording Forms were double entered into an ACCESS database, and
then transferred to EXCEL for cleaning. The following variables were selected for analysis: age,
sex, classification of severity of pneumonia, any recorded comorbid conditions (included
malaria, malnutrition, severe anaemia, meningitis and sepsis), origin of referral (self or transfer
from a primary health care centre), antibiotic use prior to admission, and treatment given. See
Table 2 for frequency of variables.
Statistical Analysis
Data were analysed using SPSS, version 7.5 for Windows and web-based OpenEpi (version
2.3). Because of the large sample size an effect size was arbitrary set at<0.67 and>1.5 to deter-
mine the importance of the odds ratio (OR). A probability level of<0.05 was considered signif-
icant and was used for inference.
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Logistic regression analysis was performed to determine the association between variables
by estimating the OR and 95% Confidence Intervals (CI) were calculated. Logistic regression
was run to measure the independent effects of the significant variables on outcome—the pro-
portion of the children who died while in hospital or case-fatality rate (CFR) was the primary
outcome indicator measured. The OR and 95% CI were calculated to estimate the risk adjusting
for potential confounders.
Table 1. WHO standard case management of pneumonia defined by age groups and severity of disease.
Standard Case Management
Diagnosis Presenting signs and symptoms Recommended treatment regimens
Child 2–59 months
Severe pneumonia Respiratory rate (bpm): Penicillin 50 000 units/kg 6 hourly for 3
 50 aged 2–11 months days if improved then oral amoxicillin 25
 40 aged 12–59 months mg/kg three times daily for total of 5 to 8
Lower chest wall indrawing days
Very severe Respiratory rate (bpm):
pneumonia  50 aged 2–11 months Chloramphenicol 25 mg/kg 8 hourly for 5
 40 aged 12–59 months days if improved then three times daily for
Lower chest wall indrawing total of 10 days antibiotic treatment
Cyanosis
Unable to drink
Reduced level of consciousness
Grunting (infants)
Infant <2 months
Severe/Very severe Respiratory rate (bpm): Gentamicin 7.5 mg/kg once daily for 8 days
pneumonia  60 Penicillin 50 000units/kg 6 hourly for three
days if improved then oral amoxicillin 25
mg/kg three times daily for a total of 8 days
antibiotic treatment
Co-morbid conditions/pneumonia treatment
Pneumonia in Signs and symptoms for severe Cotrimoxazole prophylaxis on admission if
severely /very severe pneumonia as above. not acutely ill
malnourished child PLUS signs and symptoms for any Treatment for severe or very severe
of the following: pneumonia as above PLUS
• Marasmus Gentamicin (7.5 mg/kg IM/IV) once daily for
• Kwashiorkor 7 days
• <60% Weight for Height ➤If the child fails to improve within 48 hours,
add Chloramphenicol (25 mg/kg IM/IV 8-
hourly) for 5 days.
Known/suspected 2–6-month-old child with central Continue ﬁrst-line antibiotic (such as
PcP cyanosis Chloramphenicol) as mixed infection with
Hyper-expanded chest bacteria occurs
Fast breathing Oral Cotrimoxazole: 120mg three times
Chest X-ray changes, but chest daily if less than 5 kg; 240 mg three times
clear on auscultation daily if 5 kg or more for 21 days
Enlarged liver, spleen, lymph
nodes
HIV test positive in mother or child
doi:10.1371/journal.pone.0133365.t001
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Ethical considerations
The CLHP was standard practice of patient management and data from it was routinely col-
lected. Patient identifiers such as names, geographic location by sub-district, patient registra-
tion number and specific date (except month and year) of admission were not included in
database. Permission to use the data was received from the Ministry of Health, Republic of
Malawi. Approval to analyze the data was obtained from the International Union Against
Tuberculosis and Lung Disease (The Union) Ethical Advisory Group (EAG: 05/10) and the
Human Research Ethics Committee (N10/09/285), Faculty of Medicine and Health Sciences,
Stellenbosch University.
Table 2. Distribution of variables and CFR of consecutive children (0–59months) treated for pneumonia in district hospitals in Malawi, 2000–2003.
Variable Category Number of cases % of total 95% conﬁdence
interval
Number of deaths CFR %
lower upper
Severity grade Very severe 5015 32.0 31.2 32.7 1,100 21.9
Severe 10694 68.0 67.3 68.8 533 5.0
Management
Type of referral Self 12062 76.8 76.1 77.4 1146 9.5
HC 2441 15.5 14.9 16.1 338 13.8
Unknown 1206 7.7 7.39 8.1
Antibiotic prior to admission No 12288 78.2 77.6 78.9 1244 10.1
Yes 3421 21.8 21.1 22.4 389 11.4
Comorbidity
Malaria Yes 8,013 51.0 50.2 51.8 768 9.6
No 7,696 49.0 48.2 49.8 865 11.2
Malnutrition Yes 826 5.3 4.92 5.62 192 23.2
No 14,883 94.7 94.4 95.1 1441 9.7
Severe anaemia Yes 621 4.0 3.76 4.36 113 18.2
No 15,088 96 95.7 96.3 1520 10.1
Sepsis Yes 99 0.6 0.51 0.76 16 16.2
No 15,610 99.4 99.2 99.5 1617 10.4
Meningitis Yes 93 0.6 0.48 0.72 33 35.5
No 15,616 99.4 99.3 99.5 1600 10.2
Additional treatment
Oxygen Yes 1954 12.4 11.9 12.9 556 28.5
No 13754 87.6 87.0 88.0 1077 7.8
Unknown 1 0 0 0
IV ﬂuids Yes 191 1.2 1.05 1.4 79 41.4
No 15518 98.8 98.6 98.9 1554 10.0
Antimalarials Yes 6288 40.0 39.3 40.8 538 8.6
No 9420 60.0 59.2 60.7 1095 11.6
Unknown 1 0 0 0
Blood transfusion Yes 494 3.1 2.9 3.43 83 16.8
No 15215 96.9 96.6 97.1 1550 10.2
CFR: case-fatality rate; HC: Health Centre
doi:10.1371/journal.pone.0133365.t002
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Results
It was originally proposed that all information contained on each of the Inpatient Pneumonia
Recording Forms would be entered into a computer data-base program by the CLHP Coordi-
nators at each district. However, due to a larger-than-expected number of patients being admit-
ted it was not possible for the Coordinators to undertake this task routinely. In 2003 The
Union provided limited funding to the CLHP to enable it to contract a private data entry firm.
Between October 1st 2000 and June 30th 2003 there were 17,480 (99.4%, 95% CI 99.3–99.5)
Inpatient Pneumonia Recording Forms available for analysis from the 16 districts that had
implemented the project for one or more years. From these, 837 were not eligible for the study
(duplicate entries, retreatment following failure and non-severe pneumonia category), leaving
a total of 16,643 eligible patients. Of them, 934 (5.3%, 95% CI 5.0–5.7) were excluded as their
records contained insufficient data– 424 missing classification and 510 missing outcome;
15,709 children were included in the final analysis for this study.
Fig 1 shows the age distribution of the 15,709 children included this group and provides a
classic example of terminal digit preference, with ages 24, 36 and 48 months having a higher
frequency than those immediately preceding and following them.
Table 2 lists the distribution and characteristics of variables and their associated CFR. There
were 1,633 deaths with an overall CFR of 10.4% (95% CI 9.9–10.9). Very severe pneumonia
was associated with a higher CFR than those classified as severe pneumonia (CRF 21.9%, 95%
Fig 1. Age distribution of consecutive children (0–59months) treated for pneumonia in district hospitals in Malawi, 2000–2003.
doi:10.1371/journal.pone.0133365.g001
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CI 20.8–23.1, as compared with 5.0%, 95% CI 4.6–5.4). This was consistent across the range of
age (Fig 2). The majority (76.8%, 95% CI 76.1–77.4) of admissions were self-referred and these
children were less likely to have received an antibiotic prior to admission (as compared to
those referred from a primary health care centre).
Comorbid conditions were present on admission in 6,541 (61.2%, 95% CI 60.3–62.1) of
severe pneumonia cases and in 2,806 (56.5%, 95% CI 55.1–57.9) of very severe pneumonia
cases. Malaria was the most frequent comorbid condition diagnosed in 8,013 (51.0%, 95% CI
50.2–51.8) of all admitted cases.
The most frequent additional treatment modalities received were antimalarials 6,288
(40.0%, 95% CI 39.3–40.8) or oxygen therapy 1,954 (12.4%, 95% CI 11.9–12.9).
Table 3 shows crude and adjusted odds ratios and their 95% CI for the variables studied.
The highest adjusted odds ratio for death was for those children with very severe pneumonia
(OR 4.05, 95% CI 3.53–4.64).
Self-referral was associated with a significantly higher CFR while receiving an antibiotic
prior to being referred to hospital was not.
Children had a significantly higher CFR with co-morbid conditions of meningitis (OR 2.49,
95% CI 1.50–4.15), malnutrition (OR 2.37, 95% CI 1.94–2.88) or severe anaemia (OR 1.41,
95% CI 1.03–1.92).
Children were more likely to die if they required supplementary oxygen (OR 2.16, 95% CI
1.85–2.51) or intravenous fluids (OR 3.02, 95% CI 2.13–4.28). Children treated with antimalar-
ials were significantly less likely to die (OR 0.65, 95% CI 0.56–0.76). Blood transfusion was no
longer significantly associated with CFR when adjusted for the other co-variants.
Of the 1,633 deaths 847 (51.9%, 95% Ci 49.4–54.3) died within 24 hours of admission. The
determinants that were significantly associated with all deaths were re-evaluated to determine
Fig 2. Case fatality rate of consecutive children (0–59months) treated for pneumonia in district hospitals in Malawi, 2000–2003 by severity grade.
For ease of comparison the children were sorted by age and then divided into ten equal groups (deciles). Consequently each of the ten deciles contains an
equal number of children.
doi:10.1371/journal.pone.0133365.g002
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their association with time of death (within or beyond 24 hours). The one factor significantly
more likely to be associated with death within 24 hours was the classification of very severe pneu-
monia (OR = 4.60, 95% CI 3.88–5.46 compared with OR = 2.92, 95% CI 2.47–3.45). Those dying
after 24 hours of admission were significantly more likely to have comorbidity of meningitis
(OR = 4.67, 95% CI 2.81–7.76 compared with OR = 1.17, 95% CI 0.54–2.54). The difference
between those dying within 24 hours and those dying later was not statistically significant for
age, malaria, malnutrition, severe anemia, oxygen therapy, IV fluids or antimalarials.
The patient disease classification was recorded for children over 2 months of age as it was
written in the Inpatient Recording Forms. Each record also contained information on clinical
symptoms and signs according to the routine practice of standard case management (Table 1).
From these symptoms and signs, a post hoc classification was developed according to the defi-
nitions used in standard case management. Moreover, children with very severe pneumonia
were recommended to receive chloramphenicol as part of their treatment, according to stan-
dard case management.
Table 4 presents the comparison for those children over 2 months of age between the
recorded classification of severity of disease with the reclassification based on the recorded clin-
ical details and whether or not the case was recorded as having been given chloramphenicol as
part of treatment. The lowest case fatality ratio was in those recorded and reclassified as having
severe pneumonia and in whom the treatment record did not include chloramphenicol (4.3%).
It was highest in children who were treated with chloramphenicol in whom 1) classification
was very severe pneumonia but reclassification was severe pneumonia (26.5%), 2) classification
was severe pneumonia and reclassification was very severe pneumonia (25.2%) and 3) both
classification and reclassification indicated very severe pneumonia (21.3%). In all instances
CFR was higher when chloramphenicol was given than when it wasn’t regardless of concor-
dance of classification / reclassification.
Discussion
We found a high mortality in a large cohort of 15,709 Malawian infants and children with
severe pneumonia managed in 16 district hospitals. The CFR is similar to that previously
Table 3. Crude and adjusted odds ratios from logistic regression for mortality onmanagement and comorbidity covariates adjusted for age, sex
and severity grade of consecutive children (0–59months) treated for pneumonia in district hospitals in Malawi, 2000–2003.
Crude Adjusted
Variable OR 95% CI OR 95% CI
lower upper lower upper
Very severe vs severe pneumonia 5.36 4.80 5.98 4.05 3.53 4.64
Self, vs health centre, referral 0.65 0.57 0.74 1.32 1.13 1.55
Antibiotic prior to admission 0.88 0.78 0.99 0.99 0.85 1.14
Malaria 0.84 0.76 0.93 1.07 0.92 1.24
Malnutrition 2.83 2.38 3.35 2.37 1.94 2.88
Severe anaemia 1.99 1.61 2.45 1.41 1.03 1.92
Sepsis 1.67 0.97 2.86 1.07 0.32 3.59
Meningitis 4.82 3.14 7.39 2.49 1.50 4.15
Oxygen 4.68 4.17 5.26 2.16 1.85 2.51
IV ﬂuids 6.43 4.73 8.49 3.02 2.13 4.28
Antimalarials 0.71 0.62 0.79 0.65 0.56 0.76
Blood transfusion 1.78 1.39 2.27 1.10 0.77 1.57
doi:10.1371/journal.pone.0133365.t003
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reported for an even larger cohort of which this group reported here represent a sub-set. [17]
The majority of cases presented to the hospital directly.
The commonest co-morbidity was malaria which was diagnosed in half of the cases. Fea-
tures associated with an increased pneumonia-related mortality were the severity of pneumo-
nia and the presence of co-morbidities such as malnutrition, severe anaemia or meningitis.
While none of these associations is unexpected, the unique characteristic of the study is that
these features have been analysed following prospective and complete clinical data collection
from children managed under routine conditions at a district hospital level in a high mortality
setting.
While data from a routine setting is a strength of the study, there are a number of important
limitations that must be acknowledged. A major limitation of our study was that HIV preva-
lence data were not available for this cohort. While health workers were trained to recognise
and treat Pneumocystis jirovecii pneumonia (PcP) and other HIV-related lung disease, this
almost certainly did not occur as almost all participants’HIV status was recorded as unknown.
The lack of testing reflected both a lack of policy of routine testing in children with severe
pneumonia, and a lack of willingness by health workers to undertake testing due to stigma
compounded by a lack of access to anti-retroviral therapy at the time of the study.
However, the potential importance of HIV as a common co-morbidity in Malawian infants
and children with severe pneumonia that had an impact on aetiology and outcome is recog-
nised from studies reported from urban-based tertiary hospitals in Malawi and the region. [9]
PcP is a common and often fatal cause of severe or very severe pneumonia in HIV-infected
Malawian infants, especially between 2 and 6 months of age, and is likely to have contributed
to the age-related mortality that was noted (Fig 2). [18,19] Clinical overlap with other patho-
gens, such asMycobacterium tuberculosis and non-typhoidal Salmonella, both common in
Malawi, may also have lessened the beneficial effect of the intervention as they would not be
responsive to standard first-line antibiotic therapy. This issue was addressed more extensively
in previously related article of the larger study group. [17]
A second limitation is that classification of severity grade, and therefore of “correct versus
incorrect” antibiotic usage assumes that clinical signs and symptoms recorded on the Inpatient
Pneumonia Recording Forms were accurate, but there is no way of verifying if this was the
case. The decision to prescribe more powerful antibiotics was most closely associated with the
likelihood of children dying. This suggests that a more accurate overall assessment of severity,
Table 4. Concordance of recorded and reclassified severity of disease, recorded antibiotic treatment and death while on treatment for children
greater than 2 months of age in children treated for pneumonia in district hospitals in Malawi, 2000–2003.
Classiﬁcation Antibiotic Total Died
Recorded Reclassiﬁed Chloramphenicol No Yes
on admission prescribed on admission n = % n = % n = %
All 14,047 100.0 12,599 89.7 1,448 10.3
Severe Severe no 6,865 100.0 6,570 95.7 295 4.3
Severe Severe yes 183 100.0 154 84.2 29 15.8
Severe Very severe no 2,794 100.0 2,647 94.7 147 5.3
Severe Very severe yes 127 100.0 95 74.8 32 25.2
Very severe Severe no 86 100.0 72 83.7 14 16.3
Very severe Severe yes 1,558 100.0 1,145 73.5 413 26.5
Very severe Very severe no 96 100.0 77 80.2 19 19.8
Very severe Very severe yes 2,338 100.0 1,839 78.7 499 21.3
doi:10.1371/journal.pone.0133365.t004
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as opposed to the severity category recorded in the case file, was used in the decision to use a
more powerful antibiotic. At least the choice of antibiotic was not affected by a lack of availabil-
ity in this study as implementation of the CLHP ensured availability of all antibiotics and no
stock-outs. [16,17]
We were surprised to discover the extent of misclassification in this group of patients as we
had previously concluded that standard case management was an important approach to
reduce case fatality in this setting. We were unable to judge the extent of misclassification in
our previous study [17] because we reported only aggregate data from routine reports. It was
only when we analysed individual data in this part of the study that we were able to determine
the extent of the misclassification, hence justifying the importance of analysing individual data
in addition to reporting the results from analysis of aggregate data.
In the last decade the Ministry of Health have introduced a number of strategies that will
have impacted on today’s pneumonia rates, care and outcomes. In 2005 based on results show-
ing the efficacy of the use of cotrimoxazole preventive therapy (CPT) in the reduction of mor-
tality and morbidity from opportunistic infections in HIV positive adults and children the
Ministry of Health introduced a general policy on its use in Malawi. This included all children
born to an HIV-positive woman aged 6 weeks or more and that they should receive CPT until
HIV is excluded. Also included in the policy was that any HIV-positive child 6 weeks or above
irrespective of symptoms, needs CPT prophylaxis for life. [20–22]
In July 2011, the Malawi Ministry of Health implemented ‘Option B+’ nationally, a policy to
initiate ART for life, regardless of CD4 count, for all HIV-positive pregnant or breastfeeding
women. Babies born to HIV positive mothers should also receive 6 weeks of nevirapine, PCR-
based HIV screening at 6 weeks, additional rapid testing at 12 months and 24 months and start
on ART if HIV-positive. [23–25]. These improved HIV/AIDS services in the country would be
expected to also improve outcome of treatment of children with pneumonia.
Another limitation to the study is that the diagnosis of other co-morbidities was usually
clinical without laboratory confirmation such as for malaria, sepsis or severe anaemia. There-
fore, it cannot be determined whether these conditions were under-diagnosed or over-diag-
nosed, especially as there is clinical overlap with severe pneumonia. [26] Further, while
recognised as co-morbidities that can influence outcome, the evidence of association for this
study is weakened by the lack of laboratory confirmation. Similarly, malnutrition is a major
recognised co-morbidity that increases pneumonia incidence and worsens the prognosis,
[5,7,8] but objective measure of nutritional status, that is weight-for-age, has not been deter-
mined for this study and will be presented in a separate publication.
We did not collect data onHaemophilus influenzae type b (Hib) vaccine as this was not
available when the CLHP developed and introduced the Inpatient Pneumonia Recording
Forms in October 2000. Hib vaccine did not become available until 2002 and was limited to
children who had not received their third DPT dose at the time of vaccine introduction. The
data collected for this study only went up to 30 June 2003. This is a limitation of the study. The
scale-up of Hib vaccine since 2002 and the inclusion of the 13-valent PCV into the Malawi EPI
schedule since November 2011 is likely to further reduce the incidence and CFR of pneumonia
in young children irrespective of HIV status. [27,28]
Those that received antibiotics prior to admission overall had worse outcomes. Those that
attended and received an antibiotic at a primary care facility prior to admission to the district
hospital had more severe disease, and severity of disease is strongly associated with outcome.
This is mostly due to delayed presentation at primary care level. The fact that they were
referred means they had a severe classification and severe classification is likely if they present
late to a primary care facility and hence the poor outcome. This is the most likely explanation
of the loss of significance of this factor in the multivariate analysis. We were also not able to
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determine other related issues of access to care or distance from facilities, or other socio-eco-
nomic or behavioural factors that also determine use of care facilities and duration of symp-
toms before presentation.
Previous studies have noted major deficiencies with quality of care at the district hospital
setting in many resource-limited settings. [29–31] Quality of care along with ready availability
of effective therapy such as antibiotics and oxygen have an impact on outcome. [32] Efforts
were made to minimise the impact of these important potential confounders on outcomes in
this study population. This study was undertaken following training of health workers on stan-
dard case management as well as ensuring provision of an uninterrupted supply of antibiotics
and oxygen therapy. However, despite a one-week training course, large numbers of children
were still incorrectly classified. One issue that could not be addressed was the low staff numbers
and the high turnover in all settings. [17]
It was noted that the provision of oxygen therapy, intravenous fluids or blood transfusion
were all independently associated with a significantly higher CFR. The use of these therapies
are all likely indicators of the severity of pneumonia and the presence of co-morbidities. Sever-
ity of hypoxaemia in children with pneumonia is associated with an increased risk of death.
[33] There is clear evidence that oxygen therapy improves outcome in children with severe
pneumonia, and that the routine use of oximetry improves effectiveness of oxygen therapy as it
is more sensitive and specific for identifying hypoxaemic children than clinical indicators. [34]
It is likely that in our study, the most hypoxaemic children were selected for oxygen therapy as
pulse oximetry was not routinely available in this study and clinical indicators were relied
upon. This is supported by the observation that mortality was higher in those that received
oxygen, which reflects severity rather than impact of oxygen. The poor outcome in those
receiving oxygen also suggests that PcP was not uncommon in this cohort. [32]
This study has identified several co-morbidities such as malnutrition and severe anaemia
for which prevention is called for to improve the health of these vulnerable children. It also
identified a number of potentially modifiable aspects of care where adjustments to the imple-
mentation of SCM are indicated. These include enhancing correct classification of the severity
of the disease, the use of correct antibiotics according to standard case management, more
extensive availability and use of oxygen together with oximetry to guide its use, universal test-
ing for HIV and more routine use of simple laboratory tests to detect malaria and anaemia. To
improve the outcome of these children with pneumonia, structural improvements are needed
to address these needs. In addition, more comprehensive training to deal with co-morbid con-
ditions might improve the quality of care. Further research is needed to investigate the process
of transfer to hospital through the primary services and to demonstrate how laboratory services
could be more efficiently used.
In conclusion, pneumonia-related mortality is common in Malawian infants and children
cared for in the routine care hospital setting. Reducing mortality might be achieved through
improved assessment, more rigorous application of standard case management and more accu-
rate identification and effective management of co-morbidities.
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